XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF EQUITY - 3 months ended Mar. 31, 2018 - USD ($)
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Noncontrolling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2017 $ 115,000,000     $ 75,000,000     $ 2,253,000 $ 2,679,221,000 $ 932,277,000 $ (1,270,013,000) $ 48,440,000 $ 2,582,178,000
Beginning Balance (in shares) at Dec. 31, 2017 4,600,000     3,000,000     225,321,660          
Increase (Decrease) in Stockholders' Equity                        
Deferred stock compensation, net             $ 3,000 (2,122,000)       (2,119,000)
Deferred stock compensation, net (in shares)             293,052          
Common stock distributions and distributions payable                   (11,281,000)   (11,281,000)
Preferred stock dividends and dividends payable   $ (1,998,000) $ (1,998,000)   $ (1,209,000) $ (1,209,000)            
Distributions to noncontrolling interest                     (1,169,000) (1,169,000)
Net income                 36,016,000   2,439,000 38,455,000
Ending Balance at Mar. 31, 2018 $ 115,000,000     $ 75,000,000     $ 2,256,000 $ 2,677,099,000 $ 968,293,000 $ (1,284,501,000) $ 49,710,000 $ 2,602,857,000
Ending Balance (in shares) at Mar. 31, 2018 4,600,000     3,000,000     225,614,712